Colgate-Palmolive Company (CL) Shares Sold by Broderick Brian C
Broderick Brian C reduced its position in shares of Colgate-Palmolive Company (NYSE:CL) by 1.7% during the second quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 9,744 shares of the company’s stock after selling 166 shares during the period. Broderick Brian C’s holdings in Colgate-Palmolive were worth $722,000 as of its most recent filing with the SEC.
Other large investors have also modified their holdings of the company. TIAA CREF Investment Management LLC increased its stake in shares of Colgate-Palmolive by 84.2% in the first quarter. TIAA CREF Investment Management LLC now owns 4,554,989 shares of the company’s stock worth $333,380,000 after buying an additional 2,082,262 shares during the last quarter. Swiss National Bank increased its stake in shares of Colgate-Palmolive by 22.2% in the first quarter. Swiss National Bank now owns 3,667,072 shares of the company’s stock worth $268,393,000 after buying an additional 666,400 shares during the last quarter. Karp Capital Management Corp increased its stake in shares of Colgate-Palmolive by 3,749.4% in the first quarter. Karp Capital Management Corp now owns 381,210 shares of the company’s stock worth $27,901,000 after buying an additional 371,307 shares during the last quarter. Teachers Advisors LLC increased its stake in shares of Colgate-Palmolive by 25.4% in the first quarter. Teachers Advisors LLC now owns 1,814,250 shares of the company’s stock worth $132,785,000 after buying an additional 367,977 shares during the last quarter. Finally, Scopus Asset Management L.P. acquired a new stake in shares of Colgate-Palmolive during the first quarter worth $25,617,000. 73.69% of the stock is owned by institutional investors.
Shares of Colgate-Palmolive Company (CL) traded down 0.39% during trading on Friday, hitting $71.02. The stock had a trading volume of 3,317,565 shares. The firm has a 50 day moving average of $72.30 and a 200 day moving average of $72.91. Colgate-Palmolive Company has a 1-year low of $63.43 and a 1-year high of $77.27. The company has a market capitalization of $62.56 billion, a price-to-earnings ratio of 26.39 and a beta of 0.80.
Colgate-Palmolive (NYSE:CL) last issued its earnings results on Friday, July 21st. The company reported $0.72 earnings per share (EPS) for the quarter, hitting the Zacks’ consensus estimate of $0.72. Colgate-Palmolive had a return on equity of 3,121.95% and a net margin of 15.83%. The firm had revenue of $3.83 billion for the quarter, compared to analysts’ expectations of $3.89 billion. During the same quarter last year, the business earned $0.70 earnings per share. The company’s revenue was down .5% compared to the same quarter last year. Analysts expect that Colgate-Palmolive Company will post $2.89 EPS for the current fiscal year.
The firm also recently disclosed a quarterly dividend, which was paid on Tuesday, August 15th. Stockholders of record on Tuesday, July 18th were issued a dividend of $0.40 per share. This represents a $1.60 annualized dividend and a dividend yield of 2.25%. The ex-dividend date of this dividend was Friday, July 14th. Colgate-Palmolive’s dividend payout ratio (DPR) is presently 59.48%.
ILLEGAL ACTIVITY NOTICE: This report was originally reported by Daily Political and is owned by of Daily Political. If you are reading this report on another website, it was stolen and reposted in violation of U.S. & international copyright and trademark legislation. The correct version of this report can be accessed at https://www.dailypolitical.com/2017/08/20/colgate-palmolive-company-cl-shares-sold-by-broderick-brian-c.html.
Several analysts have issued reports on CL shares. Zacks Investment Research downgraded Colgate-Palmolive from a “buy” rating to a “hold” rating in a report on Wednesday, May 3rd. Jefferies Group LLC restated a “hold” rating and set a $76.00 price objective on shares of Colgate-Palmolive in a report on Wednesday, May 17th. Bank of America Corporation boosted their price objective on Colgate-Palmolive from $78.00 to $80.00 and gave the stock a “buy” rating in a report on Wednesday, May 31st. BidaskClub downgraded Colgate-Palmolive from a “sell” rating to a “strong sell” rating in a report on Wednesday, July 12th. Finally, Vetr downgraded Colgate-Palmolive from a “buy” rating to a “hold” rating and set a $76.67 price objective on the stock. in a report on Wednesday, May 17th. Two equities research analysts have rated the stock with a sell rating, twelve have issued a hold rating and two have assigned a buy rating to the stock. The company currently has an average rating of “Hold” and a consensus target price of $75.82.
In other news, insider Patricia Verduin sold 3,833 shares of Colgate-Palmolive stock in a transaction dated Monday, July 17th. The stock was sold at an average price of $72.41, for a total transaction of $277,547.53. Following the transaction, the insider now owns 53,022 shares in the company, valued at approximately $3,839,323.02. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. Also, Vice Chairman Franck J. Moison sold 35,000 shares of Colgate-Palmolive stock in a transaction dated Monday, August 7th. The shares were sold at an average price of $71.52, for a total value of $2,503,200.00. Following the transaction, the insider now owns 201,411 shares in the company, valued at approximately $14,404,914.72. The disclosure for this sale can be found here. Insiders have sold a total of 221,802 shares of company stock worth $15,983,976 in the last quarter. 1.02% of the stock is currently owned by company insiders.
Colgate-Palmolive Company Profile
Colgate-Palmolive Company (Colgate) is a consumer products company. The Company operates in two product segments: Oral, Personal and Home Care, and Pet Nutrition. The Oral, Personal and Home Care product segment is operated through five geographic segments, which include North America, Latin America, Europe, Asia Pacific and Africa/Eurasia.
Receive News & Ratings for Colgate-Palmolive Company Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Colgate-Palmolive Company and related companies with MarketBeat.com's FREE daily email newsletter.